The DeepIntent Marketing Team
DeepIntent
Team Members:
Jacklyn Alford, Lead Brand Designer
Britney Berardelli, Senior Content Marketing Manager
Stefanie DeSantis, VP of Growth Marketing
Teresa Feely, VP of Product Marketing
Lana Fox, Senior Brand Marketing Manager
Kim Gleason, Director of Event Marketing
Marcella Milliet Sciorra, Chief Marketing Officer
Mike O’Brien, Brand Storyteller
Emily Reeves, Product Marketing Coordinator
Ellie Rush, Event Marketing Coordinator
Jason Sorrenti, Website Developer/Graphic Designer
(Photo Above) Back row, left to right: Jacklyn Alford, Jason Sorrenti, Kim Gleason, Stefanie DeSantis, Emily Reeves, Ellie Rush, Lana Fox, and Teresa Feely. Front row, left to right: Britney Berardelli, Marcella Milliet Sciorra, and Mike O’Brien.
Increasing CTV Awareness and Education
Pharma marketers have traditionally prioritized linear TV, a tried-and-true channel that accounted for 70% of the industry’s ad spend in 2021. Since then, the industry has increasingly embraced connected TV (CTV). DeepIntent firmly believes CTV is “the new brand battlefield” for pharma companies, having seen a 240% year-over-year increase in platform spend last year. However, CTV is still a relatively new channel for many pharma brands.
Under the leadership of CMO Marcella Milliet Sciorra, DeepIntent’s marketing team has recognized an industry-wide appetite for CTV education and has spent the past year focused on exactly that, driving brand awareness and demand generation.
In 2022, DeepIntent launched three whitepapers, all with different spins on CTV. “Seeing TV Differently: A CTV 101 Guide for Pharma Marketers” is full of foundational knowledge, including a glossary of acronyms from AVOD to vMVPD. “Looking Beyond Linear” showed pharma marketers how to capitalize on the channel, complete with insights from CTV heavyweights including LG Ads Solutions, FreeWheel, and Tubi. Based on an extensive survey, “Patient Views During the CTV Renaissance” focused on people’s attitudes toward pharma advertising, CTV advertising, and pharma advertising on CTV. Promoted across every owned and paid channel, these three assets’ landing pages have collectively driven 3% of DeepIntent’s site traffic over the past year.
In May, DeepIntent launched “Innovating with Intent: A Pharma-Focused CTV Forum,” the first-ever event focused exclusively on CTV for pharma advertising. The event was such a resounding success that it’s evolved into an annual tentpole event; the next one will take place this May. Capitalizing on that momentum, DeepIntent was the marquee sponsor at Digital Pharma East where DeepIntent announced a CTV-centric enhancement to DeepIntent Outcomes™, which now offers pharma advertisers the ability to measure the real-world effectiveness of their entire media across all channels, including linear TV, CTV, social media, website, search, email, and more.
The team’s efforts have made DeepIntent one of the most recognized healthcare advertising platforms in the industry.
